结直肠癌的潜在调节和预后模型与细胞外基因基因矩阵
Xiaobao Yang1,2,3, Jiale Gao1,2,3, Tianzhen Zhang1,2,3
1Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Heliyon
|September 9, 2024
概括
结直肠癌 (CRC) 的细胞外基质 (ECM) 显著影响患者的存活率和瘤进展. 针对特定的ECM基因可能为CRC治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 结直肠癌 (CRC) 中的瘤微环境 (TME) 包括细胞外基质 (ECM),它影响癌症的进展.
- 在CRC中ECM的监管作用和预测潜力尚未完全理解.
研究的目的:
- 分析CRC瘤和正常组织中的ECM特征.
- 为了确定参与ECM生产的细胞类型和调节者.
- 开发基于ECM组件的CRC预后模型.
主要方法:
- 对CRC瘤和配对正常组织的转录组分析.
- 功能丰富分析和单细胞测序以识别ECM组件和生产细胞.
- 使用TCGA-CRC队列数据开发预后模型.
主要成果:
- 瘤中明显的ECM模式与患者的存活率相关.
- 上调的ECM组件与与癌症相关的途径有关.
- 一个基于五个ECM基因 (THBS3,LAMB3,ESM1,SPRX,COL9A3) 的预后模型显示了与免疫抑制和瘤血管生成的联系.
结论:
- ECM组件参与细胞与细胞相互作用,与瘤发育和生存率低下相关.
- 已识别的ECM基因及其调节器代表了结直肠癌的潜在治疗标.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


